In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates

International Journal of Antimicrobial Agents

Volumn 43, Issue 6, 2014, Pages 527-532

  Landman, David ^a   Singh, Manisha ^a   El Imad, Badiaa ^a   Miller, Ezra ^a   Win, Thida ^a   Quale, John ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Acinetobacter baumannii; Klebsiella pneumoniae; Multidrug resistant; Pseudomonas aeruginosa

Indexed keywords

AGAR; AMIKACIN; AZTREONAM; BAL 30072; BETA LACTAM ANTIBIOTIC; COLISTIN; MEROPENEM; SIDEROPHORE MONOSULFACTAM ANTIBIOTIC; TAZOBACTAM; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; MONOBACTAM DERIVATIVE; THIAZOLE DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CITY; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; HOSPITAL; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; UNITED STATES; DRUG EFFECTS; GRAM NEGATIVE INFECTION; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MONOBACTAMS; NEW YORK CITY; PSEUDOMONAS AERUGINOSA; THIAZOLES;

EID: 84902082853     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.02.017     Document Type: Article

References (23)

1. D. Landman, E. Babu, N. Shah, P. Kelly, O. Olawole, and M. Backer et al. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration J Antimicrob Chemother 67 2012 1427 1431
2. N.Y. Lee, H.C. Lee, N.Y. Ko, C.M. Chang, H.L. Shih, and C.J. Wu et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia Infect Control Hosp Epidemiol 28 2007 713 719
3. M.J. Schwaber, S. Klarfeld-Lidji, S. Navon-Venezia, D. Schwartz, A. Leavitt, and Y. Carmeli Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality Antimicrob Agents Chemother 52 2008 1028 1033 (Pubitemid 351358384)
4. The Brooklyn Antibiotic Resistance Task Force. The cost of antibiotic resistance: effect of resistance among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa on length of hospital stay Infect Control Hosp Epidemiol 23 2002 106 108
5. R. Watson Europe launches 12 point plan to tackle antimicrobial resistance BMJ 343 2011 d7528
6. Infectious Diseases Society of America The 10 × '20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020 Clin Infect Dis 50 2010 1081 1083
7. S. Mushtaq, M. Warner, and D. Livermore Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters J Antimicrob Chemother 65 2010 266 270
8. M.G.P. Page, C. Dantier, and E. Desarbre In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant Gram-negative bacilli Antimicrob Agents Chemother 54 2010 2291 2302
9. P.G. Higgins, D. Stefanik, M.G.P. Page, M. Hackel, and H. Seifert In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii J Antimicrob Chemother 67 2012 1167 1169
10. T.A. Russo, M.G.P. Page, J.M. Beanan, R. Olson, A.M. Hujer, and K.M. Hujer et al. In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii J Antimicrob Chemother 66 2011 867 873
11. S. Mushtaq, N. Woodford, R. Hope, R. Adkin, and D.M. Livermore Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters J Antimicrob Chemother 68 2013 1601 1608
12. B. Hofer, C. Dantier, K. Gebhardt, E. Desarbre, A. Schmitt-Hoffmann, and M.G. Page Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli J Antimicrob Chemother 68 2013 1120 1129
13. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Document M07-A9 9th ed. 2012 CLSI Wayne, PA
14. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21 2012 CLSI Wayne, PA
15. J. Quale, S. Bratu, J. Gupta, and D. Landman Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates Antimicrob Agents Chemother 50 2006 1633 1641
16. S. Bratu, D. Landman, D.A. Martin, C. Georgescu, and J. Quale Correlation of antimicrobial resistance with β-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City Antimicrob Agents Chemother 52 2008 2999 3005
17. S. Bratu, D. Landman, A. George, J. Salvani, and J. Quale Correlation of the expression of acrB and the regulatory genes marA, soxS, and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City J Antimicrob Chemother 64 2009 278 283
18. D. Landman, S. Bratu, and J. Quale Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae J Med Microbiol 58 2009 1303 1308
19. S. Bratu, P. Tolaney, U. Karumudi, J. Quale, M. Mooty, and S. Nichani Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents J Antimicrob Chemother 56 2005 128 132 (Pubitemid 41418346)
20. S. Navon-Venezia, A. Leavitt, and Y. Carmeli High tigecycline resistance in multidrug-resistant Acinetobacter baumannii J Antimicrob Chemother 59 2007 772 774 (Pubitemid 47078722)
21. D. Landman, C. Georgescu, D. Martin, and J. Quale Polymyxins revisited Clin Microbiol Rev 21 2008 449 465
22. T. Walsh, J. Weeks, M. Toleman, W. Stubbings, M. Page, and M. Jones Activity of the novel sulfactam BAL30072, alone and in combination with meropenem, against Enterobacteriaceae harbouring the NDM-1 β-lactamase 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) May 7-10, 2011 2011 European Society of Clinical Microbiology and Infectious Diseases Milan, Italy [abstract P1146]
23. M. Tumbarello, P. Viale, C. Viscoli, E.M. Trecarichi, F. Tumietto, and A. Marchese et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy Clin Infect Dis 55 2012 943 950